Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Robinson, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Milton M. Hom, Od, Faao
Azusa, California, United States
- Global Research Management
Glendale, California, United States
- Eye Research Foundation
Newport Beach, California, United States
- North Bay Eye Associates, Inc.
Petaluma, California, United States
- Eric M. White Od Inc
San Diego, California, United States
- Wolstan & Goldberg Eye Associates
Torrance, California, United States
- Nature Coast Clinical Research
Crystal River, Florida, United States
- Bowden Eye & Associates
Jacksonville, Florida, United States
- South Florida Research Center, Inc.
Miami, Florida, United States
- Vista Health Research, Llc
Miami, Florida, United States
- Clinical Research Center of Florida
Pompano Beach, Florida, United States
- Georgia Eye Partners
Atlanta, Georgia, United States
- Clayton Eye Clinical Research, Llc
Morrow, Georgia, United States
- Alliance for Multispecialty Research, Llc
Newton, Kansas, United States
- Kannarr Eye Care, Llc
Pittsburg, Kansas, United States
- Senior Health Services
Louisville, Kentucky, United States
- Moyes Eye Center
Kansas City, Missouri, United States
- Ophthalmology Associates
Saint Charles, Missouri, United States
- Eye Care Associates of Nevada
Sparks, Nevada, United States
- Rochester Ophthalmological Group, Pc
Rochester, New York, United States
- Wake Forest Health Network Ophthalmology - Oak Hollow
High Point, North Carolina, United States
- Eye Care Associates of Greater Cincinnati, Inc. Dba Apex Eye
Cincinnati, Ohio, United States
- West Bay Eye Associates
Warwick, Rhode Island, United States
- Total Eye Care, Pa
Memphis, Tennessee, United States
- Advancing Vision Research
Nashville, Tennessee, United States
- Dct-Shah Research, Llc Dba Discovery Clinical Trials
Mission, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2020
- Primary completion
- 15 Jun 2021
- Completion
- 15 Jun 2021
- Last update posted
- 26 Jun 2024
- Registered enrollment
- 400
- Registry id
- NCT04393441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.